We are live on ! Find out more
SYRA

Syra Health Corp. Class A Common Stock
SYRA

Delisted

SYRA was delisted on the 17th of April, 2025.

Back to rankings

2 hedge funds and large institutions have $18.8K invested in Syra Health Corp. Class A Common Stock in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% less capital invested

Capital invested by funds: $43.8K → $18.8K (-$25K)

78% less funds holding

Funds holding: 9 → 2 (-7)

78% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 9

Holders
2
Holders Change
-7
Holders Change %
-77.78%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$29.3K
2
XT
XTX Topco
Cayman Islands
+$4.36K

Top Sellers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
-$17.9K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$8.9K
3
TSS
Two Sigma Securities
New York
-$6.47K
4
UBS Group
UBS Group
Switzerland
-$5.05K
5
IWM
IHT Wealth Management
Illinois
-$3.64K

SYRA Hedge Fund Activity: Q2 2025 in Review

2 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Syra Health Corp. Class A Common Stock (SYRA) for Q2 2025, worth a combined $18.8K — down 57% from $43.8K a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of SYRA and 2 opened new positions — a net loss of 7 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Jane Street, opening a new position worth an estimated $29.3K. The largest seller was Geode Capital Management, exiting entirely with an estimated $17.9K sold.

  • 2 institutional investors held Syra Health Corp. Class A Common Stock (SYRA) as of Q2 2025, down from 9 in Q1 2025.
  • Funds reported $18.8K of Syra Health Corp. Class A Common Stock stock for Q2 2025, down 57% quarter-over-quarter.
  • 2 funds opened new Syra Health Corp. Class A Common Stock positions in Q2 2025 and 9 closed out, a net change of -7 holders.
  • The largest Syra Health Corp. Class A Common Stock buyer in Q2 2025 was Jane Street, an estimated $29.3K added.
  • The largest Syra Health Corp. Class A Common Stock seller in Q2 2025 was Geode Capital Management, an estimated $17.9K sold.

Based on aggregated 13F filings for Q2 2025.